TNFRSF1B and melanoma: One possible reason why CD271 has previously been implicated in MAPKi resistance is due to its common co-expression with TNFR1 and TNFR2, and because TNFR2 partially drives CD271 upregulation on cultured BRAFV600E+ melanoma cell lines.